Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ...

The agency has set a Prescription Drug User Fee Act ... along with reducing visits to hospital or infusion sites. The subcutaneous autoinjector dosing, which would also take far less time than ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

The administration of rHuPH20 increases the dispersion and absorption of immunoglobulin (IG) in the subcutaneous tissue, allowing larger volumes to be infused in the infusion site. This allows for ...

The FDA has started its review of a subcutaneous injection formulation ... rather than in an infusion clinic. Eisai and Biogen's filing is for a once-weekly autoinjector formulation of Leqembi ...